Previous Article | Next Article ![]()
Infect. Immun., Jan 1995, 38-42, Vol 63, No. 1
EG Rawling, NL Martin and RE Hancock
The Pseudomonas aeruginosa major outer membrane protein OprF has been
proposed for use as a vaccine and as a target for immunotherapeutic and
diagnostic monoclonal antibodies. The well-conserved epitopes for 10
surface-reactive, OprF-specific monoclonal antibodies were localized by
both overlapping peptide analysis and immunodetection of OprF peptides
generated by cyanogen bromide and the protease papain. Three of the
monoclonal antibodies bound to specific overlapping octapeptides, which had
been synthesized on 160 pins to cover the entire 326 amino acids of OprF.
The highest reactivities were as follows: MA7-1 to the pin with attached
peptide GTYETGNK (amino acids 55 to 62), MA7-2 to NLADFMKQ (amino acids 237
to 244), and MA5-8 to TAEGRAIN (amino acids 307 to 314). The other
monoclonal antibodies showed no reactivity, indicating that they do not
recognize linear epitopes. Two polyclonal sera were also tested and
demonstrated weak reactivity with discrete regions of OprF, suggesting that
the majority of antibodies produced might recognize conformational
epitopes. Utilizing defined peptides generated with cyanogen bromide and
papain, the conformational epitopes recognized by the seven monoclonal
antibodies were localized to regions that were 42 to 90 amino acids long.
These regions were located on two adjacent loops in the middle of an
amended structural model of OprF.
Copyright © 1995, American Society for Microbiology
Epitope mapping of the Pseudomonas aeruginosa major outer membrane porin protein OprF
Department of Microbiology, University of British Columbia, Vancouver, Canada.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|